Barclays PLC Has $66,000 Holdings in Cibus, Inc. (NASDAQ:CBUS)

Barclays PLC boosted its position in shares of Cibus, Inc. (NASDAQ:CBUS) by 287.2% in the third quarter, Holdings Channel reports. The fund owned 20,269 shares of the company’s stock after acquiring an additional 15,034 shares during the period. Barclays PLC’s holdings in Cibus were worth $66,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. Bank of New York Mellon Corp acquired a new position in Cibus in the second quarter worth about $529,000. Rhumbline Advisers acquired a new position in Cibus in the second quarter valued at about $221,000. Old West Investment Management LLC lifted its stake in Cibus by 3.6% in the second quarter. Old West Investment Management LLC now owns 53,247 shares of the company’s stock valued at $524,000 after buying an additional 1,868 shares in the last quarter. Squarepoint Ops LLC bought a new position in Cibus during the 2nd quarter worth about $214,000. Finally, Armistice Capital LLC acquired a new position in Cibus during the 2nd quarter worth approximately $5,083,000. Institutional investors and hedge funds own 33.81% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently commented on the company. Canaccord Genuity Group reissued a “buy” rating and set a $20.00 price target on shares of Cibus in a research report on Tuesday, October 22nd. Alliance Global Partners lowered their price target on shares of Cibus from $25.00 to $23.50 and set a “buy” rating on the stock in a research report on Tuesday, September 24th. Finally, HC Wainwright reaffirmed a “buy” rating and set a $25.00 price objective on shares of Cibus in a research report on Monday, November 11th.

Cibus Stock Performance

CBUS stock opened at $2.58 on Friday. The company has a market capitalization of $68.26 million, a P/E ratio of -0.11 and a beta of 1.85. The company has a fifty day moving average price of $3.87 and a 200-day moving average price of $5.56. Cibus, Inc. has a 52-week low of $2.35 and a 52-week high of $23.18.

Cibus Company Profile

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.